Sanofi and GlaxoSmithKline seem to be getting somewhere with their COVID-19 vaccine at last, announcing plans to move to phase 3 following supportive mid-stage trial results.
Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University's Jenner Institute has unveiled trial results showing its experimental malaria shot could be a
